17
ACCEPTED MANUSCRIPT
References
[1] M. Prudhomme, J. Guyot, G. Jeminet, Semisynthesis of A23187 (Calcimycin) Analogs .4. Cation Carrier
Properties in Mitochondria of Analogs with Modified Benzoxazole Rings - Antimicrobial Activity, J Antibiot 39(7)
(1986) 934-937.
[2] M. Arisoy, O. Temiz-Arpaci, F. Kaynak-Onurdag, S. Ozgen, Synthesis and Antimicrobial Activity of Novel
Benzoxazoles, Z Naturforsch C 67(9-10) (2012) 466-472.
[3] M. Arisoy, O. Temiz-Arpaci, F. Kaynak-Onurdag, S. Ozgen, Novel Benzoxazoles: Synthesis and Antibacterial,
Antifungal, and Antitubercular Activity against Antibiotic-Resistant and -Sensitive Microbes, Z Naturforsch C 68(11-
12) (2013) 453-460.
[4] M. Arisoy, O. Temiz-Arpaci, F. Kaynak-Onurdag, S. Ozgen, Synthesis and Antimicrobial Evaluation of 2-(p-
Substituted Phenyl)-5-[(4-substituted piperazin-1-yl)acetamido]-benzoxazoles, Z Naturforsch C 69(9-10) (2014) 368-
374.
[5] D.N. Ward, D.C. Talley, M. Tavag, S. Menji, P. Schaughency, A. Baier, P.J. Smith, UK-1 and structural analogs
are potent inhibitors of hepatitis C virus replication, Bioorg Med Chem Lett 24(2) (2014) 609-612.
[6] A. Pinar, P. Yurdakul, I. Yildiz, O. Temiz-Arpaci, N.L. Acan, E. Aki-Sener, I. Yalcin, Some fused heterocyclic
compounds as eukaryotic topoisomerase II inhibitors, Biochem Bioph Res Co 317(2) (2004) 670-674.
[7] H. Lage, E. Aki-Sener, I. Yalcin, High antineoplastic activity of new heterocyclic compounds in cancer cells with
resistance against classical DNA topoisomerase II-targeting drugs, Int J Cancer 119(1) (2006) 213-220.
[8] O. Temiz-Arpaci, T. Coban, B. Tekiner-Gulbas, B. Can-Eke, I. Yildiz, E. Aki-Sener, I. Yalcin, M. Iscan, A study
on the antioxidant activities of some new benzazole derivatives, Acta Biol Hung 57(2) (2006) 201-209.
[9] Y. Fukuda, T. Araki, T. Ohshima, K. Yoneda, Catalytic properties and crystal structure of thermostable
NAD(P)H-dependent carbonyl reductase from the hyperthermophilic archaeon Aeropyrum pernix K1, Enzyme and
Microbial Technology 91 (2016) 17-25.
[10] I. Hanukoglu, R. Rapoport, Routes and Regulation of Nadph Production in Steroidogenic Mitochondria,
Endocrine Research 21(1-2) (1995) 231-241.
[11] G.F. Rush, J.R. Gorski, M.G. Ripple, J. Sowinski, P. Bugelski, W.R. Hewitt, Organic Hydroperoxide-Induced
Lipid-Peroxidation and Cell-Death in Isolated Hepatocytes, Toxicol Appl Pharm 78(3) (1985) 473-483.
[12] A. Lagunin, A. Stepanchikova, D. Filimonov, V. Poroikov, PASS: prediction of activity spectra for biologically
active substances, Bioinformatics 16(8) (2000) 747-748.
[13] A. Kamal, K.S. Reddy, M.N.A. Khan, R.V.C.R.N.C. Shetti, M.J. Ramaiah, S.N.C.V.L. Pushpavalli, C. Srinivas,
M. Pal-Bhadra, M. Chourasia, G.N. Sastry, A. Juvekar, S. Zingde, M. Barkume, Synthesis, DNA-binding ability and
anticancer activity of benzothiazole/benzoxazole-pyrrolo[2,1-c][1,4]benzodiazepine conjugates, Bioorgan Med Chem
18(13) (2010) 4747-4761.
[14] D. Kumar, M.R. Jacob, M.B. Reynolds, S.M. Kerwin, Synthesis and evaluation of anticancer benzoxazoles and
benzimidazoles related to UK-1, Bioorgan Med Chem 10(12) (2002) 3997-4004.
[15] C.T. Zeyrek, H. Unver, O.T. Arpaci, K. Polat, N.O. Iskeleli, M. Yildiz, Experimental and theoretical
characterization of the 2-(4-bromobenzyl)-5-ethylsulphonyl-1,3-benzoxazole, J Mol Struct 1081 (2015) 22-37.
[16] M.S. Ober, Froese, R. D., Quinoline-benzoxazole derived compounds for electronic films and devices, in: D.G.T.
Llc (Ed.) 2014.
[17] Y. Kawata, Kadoma, H., Ohsawa, N., Seo, S. , Benzoxazole derivative, light-emitting element, light-emitting
device, electronic device, and lighting device, in: L. Semiconductor Energy Laboratory Co. (Ed.) 2013.
[18] M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V.
Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino,
G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y.
Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery, J.E.P. Jr., F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers,
K. N. Kudin, V. N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar,
J. Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R.
Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K.
Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, Ö. Farkas, J. B.
Foresman, J. V. Ortiz, J. Cioslowski, D.J. Fox, Gaussian 09, Revision D.01, Gaussian, Inc., Wallingford CT, 2009.
[19] R. Dennington, T. Keith, J. Millam, GaussView, Version 5, Semichem, Inc., Shawnee Mission, KS, 2009.
[20] F.F. Charlotte, General Hartree-Fock program, Computer Physics Communications 43(3) (1987) 355-365.
[21] G.A. Petersson, A. Bennett, T.G. Tensfeldt, M.A. Allaham, W.A. Shirley, J. Mantzaris, A Complete Basis Set
Model Chemistry .1. The Total Energies of Closed-Shell Atoms and Hydrides of the 1st-Row Elements, J Chem Phys
89(4) (1988) 2193-2218.
[22] T. Clark, J. Chandrasekhar, G.W. Spitznagel, P.V. Schleyer, Efficient Diffuse Function-Augmented Basis Sets
for Anion Calculations. Iii. The 3-21+G Basis Set for First-Row Elements, Li-F, J Comput Chem 4(3) (1983) 294-
301.
[23] P.P. G. Fogarasi, Ab initio calculation of force fields and vibrational spectra, Vibrational Spectra and Structure: a
Series of Advances, vol. 14 (Chapter 3), 125–219, Elsevier, Amsterdam, 1985.